A detailed history of Northern Trust Corp transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 495,090 shares of DAWN stock, worth $6.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
495,090
Previous 533,039 7.12%
Holding current value
$6.05 Million
Previous $7.35 Million 6.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$12.72 - $16.03 $482,711 - $608,322
-37,949 Reduced 7.12%
495,090 $6.9 Million
Q2 2024

Aug 14, 2024

SELL
$12.03 - $17.69 $302,025 - $444,125
-25,106 Reduced 4.5%
533,039 $7.35 Million
Q1 2024

May 14, 2024

SELL
$13.56 - $17.46 $252,310 - $324,878
-18,607 Reduced 3.23%
558,145 $9.22 Million
Q4 2023

Feb 13, 2024

BUY
$9.68 - $15.37 $241,012 - $382,682
24,898 Added 4.51%
576,752 $8.42 Million
Q3 2023

Nov 13, 2023

BUY
$11.22 - $14.86 $1.34 Million - $1.77 Million
119,262 Added 27.57%
551,854 $6.77 Million
Q2 2023

Aug 11, 2023

BUY
$11.74 - $14.47 $2.5 Million - $3.08 Million
213,071 Added 97.06%
432,592 $5.17 Million
Q1 2023

May 15, 2023

SELL
$12.75 - $23.41 $73,287 - $134,560
-5,748 Reduced 2.55%
219,521 $2.93 Million
Q4 2022

Feb 13, 2023

BUY
$18.77 - $22.0 $4,110 - $4,818
219 Added 0.1%
225,269 $4.85 Million
Q3 2022

Nov 14, 2022

BUY
$16.44 - $26.57 $567,837 - $917,727
34,540 Added 18.13%
225,050 $4.51 Million
Q2 2022

Aug 12, 2022

BUY
$5.72 - $17.9 $115,606 - $361,776
20,211 Added 11.87%
190,510 $3.41 Million
Q1 2022

May 13, 2022

BUY
$9.12 - $17.47 $607,592 - $1.16 Million
66,622 Added 64.26%
170,299 $1.69 Million
Q4 2021

Feb 08, 2022

BUY
$15.65 - $26.33 $87,295 - $146,868
5,578 Added 5.69%
103,677 $1.75 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.92 $1.71 Million - $2.38 Million
85,381 Added 671.34%
98,099 $2.33 Million
Q2 2021

Aug 13, 2021

BUY
$19.0 - $23.69 $241,642 - $301,289
12,718 New
12,718 $290,000

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $897M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.